Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBITDA Margin (2020 - 2025)

Stemtech (STEK) has disclosed EBITDA Margin for 6 consecutive years, with 14.91% as the latest value for Q3 2025.

  • Quarterly EBITDA Margin rose 20382.0% to 14.91% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 3.9% through Sep 2025, up 12227.0% year-over-year, with the annual reading at 81.25% for FY2024, 2018.0% up from the prior year.
  • EBITDA Margin hit 14.91% in Q3 2025 for Stemtech, down from 55.76% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1624.65% in Q3 2022 to a low of 1925.71% in Q2 2022.
  • Historically, EBITDA Margin has averaged 104.48% across 5 years, with a median of 48.22% in 2024.
  • Biggest YoY gain for EBITDA Margin was 226213bps in 2022; the steepest drop was -189688bps in 2022.
  • Year by year, EBITDA Margin stood at 44.53% in 2021, then skyrocketed by 81bps to 8.59% in 2022, then tumbled by -938bps to 89.08% in 2023, then surged by 131bps to 27.85% in 2024, then tumbled by -154bps to 14.91% in 2025.
  • Business Quant data shows EBITDA Margin for STEK at 14.91% in Q3 2025, 55.76% in Q2 2025, and 89.09% in Q1 2025.